SCHEMBL30707192

SCHEMBL30707192

Cc1ccc(Cl)c(CBr)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.41
SLC6A4 P31645 2/20 0.41
KCNH2 Q12809 2/20 0.41
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16998686 1.00 HTR2A (0.41) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL30474183 0.82 IDO1 (0.35) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL16998685 0.82 IDO1 (0.35) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL8237259 0.79 HTR2A (0.42) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL16752294 0.79 KMT2A (0.48) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL10019194 0.78 KCNH2 (0.39) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL233314 0.78 TAAR1 (0.41) HTR2AALDH1A1MAPTPOLBTAAR1
SCHEMBL2735698 0.77 HTR2A (0.41) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL6111929 0.77 PNMT (0.48) HTR2ASLC6A4KCNH2ALDH1A1MAPT
SCHEMBL320779 0.77 HTR2A (0.41) HTR2ASLC6A4KCNH2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540255-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 EP disclosed
WO-2023244615-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 WO disclosed